Digital Diagnostics Market Report 2026

Digital Diagnostics Market Overview

• Digital Diagnostics market size has reached to $2.15 billion in 2025 • Expected to grow to $5.83 billion in 2030 at a compound annual growth rate (CAGR) of 21.9% • Growth Driver: Increasing Number Of Chronic Illness Cases Fueling The Growth Of The Market Due To Aging Populations And Lifestyle Factors • Market Trend: Advancements In AI-Driven Cytology Systems • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Digital Diagnostics Market?

Digital diagnostics refers to the use of advanced digital technologies, such as artificial intelligence (AI), machine learning, data analytics, and imaging systems, to identify, monitor, and predict health conditions with high precision and efficiency. Leveraging electronic health records (EHRs), wearable devices, and diagnostic tools enables real-time data collection, analysis, and interpretation to assist healthcare professionals in making accurate decisions. The main products of digital diagnostics products include hardware, software, and services. Hardware in digital diagnostics refers to the physical devices used to conduct tests and gather health data. It is applied to cardiology, gynecology, infectious diseases, oncology, diabetes, and others and is used by hospitals and clinics, clinical laboratories, pharmaceutical and biotechnology companies, academic and research institutes, and others.

What Is The Digital Diagnostics Market Growth Forecast?

The digital diagnostics market size is expected to see exponential growth in the next few years. It will grow to $5.83 billion in 2030 at a compound annual growth rate (CAGR) of 21.9%. The growth in the forecast period can be attributed to advancements in ai algorithms, expansion of telehealth diagnostics, demand for early disease detection, cloud-based diagnostics adoption, interoperability standards growth. Major trends in the forecast period include growing adoption of AI-enabled diagnostic tools, expansion of remote and point-of-care diagnostics, increased use of real-time health data analytics, integration of diagnostics with ehr systems, rising demand for predictive and preventive diagnostics.

What Is The Driver Of The Digital Diagnostics Market?

The increasing number of chronic illness cases is expected to propel the growth of the digital diagnostics market going forward. Chronic illnesses are long-term health conditions that require ongoing medical attention and management, including cardiovascular diseases, diabetes, cancer, and chronic respiratory diseases. The prevalence of these diseases is rising due to aging populations and lifestyle factors such as unhealthy diets, physical inactivity, tobacco use, and environmental conditions. Digital diagnostics supports healthcare systems by providing artificial intelligence (AI)-powered diagnostic tools, remote monitoring devices, and digital health platforms that enable early detection, continuous monitoring, and personalized management of chronic conditions. For instance, in May 2023, according to the World Health Organization (WHO), a Switzerland-based healthcare organization, by around 2050, chronic diseases such as cardiovascular diseases, cancer, diabetes, and respiratory illnesses will account for 86 percent of the 90 million deaths each year. Therefore, the increasing number of chronic illness cases is driving the growth of the digital diagnostics industry.

Key Players In The Global Digital Diagnostics Market

Major companies operating in the digital diagnostics market are Hoffmann-La Roche Holding AG, Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Siemens Healthineers , Koninklijke Philips N.V., General Electric Company, Laboratory Corporation of America Holdings, Quest Diagnostics Incorporated, Hologic Inc., bioMérieux S.A., Bio-Rad Laboratories Inc., Fulgent Genetics Inc., Guardant Health Inc., Tempus Labs Inc., Genomic Health Inc., EDX Medical Inc., PathAI Inc., Healthy.io Ltd., BrightInsight Inc., Digital Diagnostics Inc., Brainomix Limited, DnaNudge Ltd., GRAIL Inc.

Global Digital Diagnostics Market Trends and Insights

Major companies operating in the digital diagnostics market are focusing on developing technologically advanced products, such as digital cytology systems, to enhance diagnostic accuracy, streamline workflows, and enable remote analysis through advanced imaging and AI-driven tools. A digital cytology system is an advanced diagnostic platform that utilizes imaging technology and artificial intelligence to analyze and interpret cytological samples for accurate and efficient medical diagnoses. For instance, in February 2024, Hologic Inc., a US-based medical technology company, announced the U.S. Food and Drug Administration (FDA) approval for its Genius Digital Diagnostics System with the Genius Cervical AI algorithm. The Genius Digital Diagnostics System is the first and only FDA-cleared digital cytology platform that integrates deep-learning-based AI with advanced volumetric imaging to identify pre-cancerous lesions and cervical cancer cells. Unlike traditional methods where cervical cells collected during a Pap test are examined manually under a microscope, this system digitizes the glass slides and uses AI to highlight key cells for cytologists and pathologists to review.

What Are Latest Mergers And Acquisitions In The Digital Diagnostics Market?

In October 2023, Kingsway Financial Services, a US-based holding company, acquired Digital Diagnostics Imaging for $11 million. Through this acquisition, Kingsway Financial Services aims to enhance its healthcare portfolio by integrating Digital Diagnostics Imaging's remote cardiac monitoring services, which will provide recurring revenue and expand its market presence in the growing field of telehealth. Digital Diagnostics Imaging is a US-based provider of digital diagnostic systems and services.

What Defines the Digital Diagnostics Market?

The digital diagnostics market consists of revenues earned by entities by providing services such as remote patient monitoring, digital imaging analysis, telehealth diagnostics, and genomic and biomarker analysis. The market value includes the value of related goods sold by the service provider or included within the service offering. The digital diagnostics market also includes sales of digital X-ray systems, point-of-care testing devices, pathology slide scanners, and genetic testing kits. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Digital Diagnostics Market Report 2026?

The digital diagnostics market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the digital diagnostics industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.